 |
 |
|
|
|
| Cortisone Acetate |
 |
| white solid |
 |
| 50-03-3 |
 |
| For the treatment of adrenal cortical low function disease, rheumatoid arthritis, rheumatism, such as lupus erythematosus disease |
 |
Cortisone Acetate
Synonyms: 11,20-trione,17,21-dihydroxy-pregn-4-ene-21-acetate
CAS:50-03-3
Molecular Formula: C23H32O6
Molecular Weight: 404.5
Chemical Properties: solid
Assay: 98%
Purity: 98%
EINECS: 200-006-5
Density
1.265g/cm3
Boiling point::577.257¡ÆC at 760 mmHg
Melting point: 237-240¡É
Flash point: : 197.345¡ÆC
Steam pressure: 0mmHg at 25¡ÆC
InChI:InChI=1/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-17,20,28H,4-9,11-12H2,1-3H3/t16-,17-,20+,21+,22+,23+/m1/s1
Properties: white or almost white crystalline powder
Odorless, tasteless early, followed a long-lasting bitterness. Insoluble in water, slightly soluble in ethanol or, soluble in chloroform.
Function of role: Adrenal hypofunction and hypopituitarism.
Application:
For the treatment of adrenal cortical low function disease, rheumatoid arthritis, rheumatism, such as lupus erythematosus disease |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
